Редактирование:
CYP27A1
Перейти к навигации
Перейти к поиску
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Sterol 26-hydroxylase, mitochondrial precursor (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase) [CYP27] ==Publications== {{medline-entry |title=Prenatal betaine exposure alleviates corticosterone-induced inhibition of [[CYP27A1]] expression in the liver of juvenile chickens associated with its promoter DNA methylation. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28039067 |abstract=Sterol 27-hydroxylase ([[CYP27A1]]) plays an important role in cholesterol homeostasis by degrading cholesterol to bile acids. Betaine can alleviate high-fat diet-induced hepatic cholesterol accumulation and maternal betaine treatment programs the hepatic expression of [[CYP27A1]] in offspring. Excessive corticosterone ([[CORT]]) exposure causes hepatic cholesterol deposition in chickens, yet it remains unknown whether prenatal betaine modulates [[CORT]]-induced cholesterol accumulation in chicken liver later in life and whether it involves epigenetic gene regulation of [[CYP27A1]]. In this study, fertilized eggs were injected with saline or betaine at 2.5mg/egg before incubation, and the hatchlings were raised under the same condition till 56days of age followed by 7days of subcutaneous [[CORT]] injection. Plasma concentrations of total cholesterol (Tch), HDL- and LDL-cholesterol were significantly increased (P<0.05), after [[CORT]] challenge, in both control and betaine groups. However, prenatal betaine exposure prevented [[CORT]]-induced increase (P<0.05) in hepatic Tch content. Hepatic expression of cholesterol biosynthesis genes and [[ACAT1]] protein that esterifies cholesterol for storage, were activated in both control and betaine groups upon [[CORT]] challenge. However, betaine-treated chickens were protected from [[CORT]]-induced repression (P<0.05) in LXR and [[CYP27A1]] expression in the liver. [[CORT]]-induced down-regulation of LXR and [[CYP27A1]] coincided with significantly increased (P<0.05) CpG methylation on their promoters, which was significantly ameliorated in betaine-treated chickens. These results suggest that in ovo betaine injection alleviates [[CORT]]-induced hepatic cholesterol deposition most probably through epigenetic regulation of [[CYP27A1]] and LXR genes in juvenile chickens. |mesh-terms=* Aging * Animals * Animals, Newborn * Anti-Inflammatory Agents * Betaine * Blotting, Western * Chickens * Cholestanetriol 26-Monooxygenase * Cholesterol * Corticosterone * DNA Methylation * Epigenesis, Genetic * Female * Gastrointestinal Agents * Gene Expression Regulation, Enzymologic * Immunoprecipitation * Lipid Metabolism * Liver * Pregnancy * Prenatal Exposure Delayed Effects * Promoter Regions, Genetic * RNA, Messenger * Real-Time Polymerase Chain Reaction * Reverse Transcriptase Polymerase Chain Reaction |keywords=* Betaine * CYP27A1 * Cholesterol * Corticosterone * DNA methylation |full-text-url=https://sci-hub.do/10.1016/j.ygcen.2016.12.014 }} {{medline-entry |title=Synergic hypocholesterolaemic effect of n-3 PUFA and oestrogen by modulation of hepatic cholesterol metabolism in female rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26388416 |abstract=n-3 PUFA such as EPA and DHA as well as oestrogen have been reported to decrease blood levels of cholesterol, but their underlying mechanism is unclear. The purpose of this study was to determine the effects of the combination of n-3 PUFA supplementation and oestrogen injection on hepatic cholesterol metabolism. Rats were fed a modified AIN-93G diet with 0, 1 or 2 % n-3 PUFA (EPA DHA) relative to the total energy intake for 12 weeks. Rats were surgically ovariectomised at week 8, and, after 1-week recovery, rats were injected with 17β-oestradiol-3-benzoate (E2) or maize oil for the last 3 weeks. Supplementation with n-3 PUFA and E2 injection significantly increased the ratio of the hepatic expression of phosphorylated AMP activated protein kinase (p-AMPK):AMP activated protein kinase (AMPK) and decreased sterol regulatory element-binding protein-2, 3-hydroxy-3-methylglutaryl coenzyme A reductase and proprotein convertase subtilisin/kexin type 9. Supplementation with n-3 PUFA increased hepatic expression of cholesterol 7α-hydroxylase ([[CYP7A1]]), sterol 12α-hydroxylase ([[CYP8B1]]) and sterol 27-hydroxylase ([[CYP27A1]]); however, E2 injection decreased [[CYP7A1]] and [[CYP8B1]] but not [[CYP27A1]]. Additionally, E2 injection increased hepatic expression of oestrogen receptor-α and β. In conclusion, n-3 PUFA supplementation and E2 injection had synergic hypocholesterolaemic effects by down-regulating hepatic cholesterol synthesis (n-3 PUFA and oestrogen) and up-regulating bile acid synthesis (n-3 PUFA) in ovariectomised rats. |mesh-terms=* Aging * Animals * Anticholesteremic Agents * Cholestanetriol 26-Monooxygenase * Cholesterol 7-alpha-Hydroxylase * Combined Modality Therapy * Diet, Fat-Restricted * Dietary Supplements * Estradiol * Estrogens * Fatty Acids, Omega-3 * Female * Hydroxymethylglutaryl CoA Reductases * Hypercholesterolemia * Liver * Ovariectomy * Proprotein Convertase 9 * Random Allocation * Rats, Wistar * Serine Endopeptidases * Steroid 12-alpha-Hydroxylase * Sterol Regulatory Element Binding Protein 2 |keywords=* n-3 PUFA * AMPK AMP activated protein kinase * CYP27A1 sterol 27-hydroxylase * CYP7A1 cholesterol 7α-hydroxylase * CYP8B1 sterol 12α-hydroxylase * Cholesterol metabolism * E2 17β-oestradiol-3-benzoate * ER-α oestrogen receptor-α * ER-β oestrogen receptor-β * HMG-CoA reductase 3-hydroxy-3-methylglutaryl coenzyme A reductase * Oestrogen * Ovariectomised rats * Proprotein convertase subtilisin/kexin type 9 * SREBP-2 sterol regulatory element-binding protein-2 * TC total cholesterol * p-AMPK phosphorylated AMP activated protein kinase |full-text-url=https://sci-hub.do/10.1017/S0007114515003517 }} {{medline-entry |title=Hepatic cholesterol metabolism following a chronic ingestion of cesium-137 starting at fetal stage in rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/20173315 |abstract=The Chernobyl accident released many radionuclides in the environment. Some are still contaminating the ground and thus the people through dietary intake. The long-term sanitary consequences of this disaster are still unclear and several biological systems remain to be investigated. Cholesterol metabolism is of particular interest, with regard to the link established between atherosclerosis and exposure to high-dose ionizing radiations. This study assesses the effect of cesium-137 on cholesterol metabolism in rats, after a chronic exposure since fetal life. To achieve this, rat dams were contaminated with cesium-137-supplemented water from two weeks before mating until the weaning of the pups. Thereafter, the weaned rats were given direct access to the contaminated drinking water until the age of 9 months. After the sacrifice, cholesterol metabolism was investigated in the liver at gene expression and protein level. The cholesterolemia was preserved, as well as the cholesterol concentration in the liver. At molecular level, the gene expressions of ACAT 2 (a cholesterol storage enzyme), of Apolipoprotein A-I and of RXR (a nuclear receptor involved in cholesterol metabolism) were significantly decreased. In addition, the enzymatic activity of [[CYP27A1]], which catabolizes cholesterol, was increased. The results indicate that the rats seem to adapt to the cesium-137 contamination and display modifications of hepatic cholesterol metabolism only at molecular level and within physiological range. |mesh-terms=* Administration, Oral * Aging * Animals * Cesium Radioisotopes * Cholesterol * Female * Liver * Male * Pregnancy * Pregnancy, Animal * Prenatal Exposure Delayed Effects * Radiation Dosage * Rats * Rats, Sprague-Dawley |full-text-url=https://sci-hub.do/10.1269/jrr.09064 }} {{medline-entry |title=Expression of key enzymes in bile acid biosynthesis during development: [[CYP7B1]]-mediated activities show tissue-specific differences. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/11971943 |abstract=The developmental variation of cytochrome P450 (CYP)7A1, [[CYP7B1]], [[CYP27A1]], and 3beta-hydroxy-Delta(5)-C(27)-steroid dehydrogenase, key enzymes in bile acid biosynthesis, were investigated in pigs of different ages. As part of these studies, peptide sequences from a purified pig liver oxysterol 7alpha-hydroxylase were analyzed. The sequences showed a high degree of identity with those of murine and human [[CYP7B1]]. Enzymatic activities and mRNA levels of [[CYP27A1]] and 3beta-hydroxy-Delta(5)-C(27)-steroid dehydrogenase were similar in livers of newborn and 6-month-old pigs. Enzymatic activity mediated by [[CYP7A1]] increased several-fold between infancy and adolescence. Hepatic [[CYP7A1]] and [[CYP7B1]] mRNA levels increased several-fold with age. Hepatic microsomal 7alpha-hydroxylation of 27-hydroxycholesterol and dehydroepiandrosterone, substrates typical for [[CYP7B1]], increased about 5-fold between infancy and adolescence whereas the activities in kidney microsomes decreased at least 10-fold. In conclusion, the results indicate that the expression of [[CYP27A1]] and 3beta-hydroxy-Delta(5)-C(27)-steroid dehydrogenase are similar in livers of newborn and 6-month-old pigs whereas the levels of [[CYP7A1]] increase. The finding that the levels of [[CYP7B1]] increase with age in the liver but decrease in the kidney suggest a tissue-specific developmental regulation of [[CYP7B1]]. The age-dependent variation in the liver and kidney suggests that hormonal factors are involved in the regulation of [[CYP7B1]]. |mesh-terms=* Aging * Amino Acid Sequence * Animals * Animals, Newborn * Base Sequence * Bile Acids and Salts * Cytochrome P-450 Enzyme System * Cytochrome P450 Family 7 * Gene Expression Regulation, Developmental * Gene Expression Regulation, Enzymologic * Humans * Kinetics * Male * Mice * Mitochondria, Liver * Molecular Sequence Data * Orchiectomy * Organ Specificity * Peptide Fragments * Polymerase Chain Reaction * Progesterone Reductase * RNA, Messenger * Sequence Alignment * Sequence Homology, Amino Acid * Steroid Hydroxylases * Swine * Transcription, Genetic }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)
Навигация
Персональные инструменты
Вы не представились системе
Обсуждение
Вклад
Создать учётную запись
Войти
Пространства имён
Статья
Обсуждение
русский
Просмотры
Читать
Править
История
Ещё
Навигация
Начало
Свежие правки
Случайная страница
Инструменты
Ссылки сюда
Связанные правки
Служебные страницы
Сведения о странице
Дополнительно
Как редактировать
Вики-разметка
Telegram
Вконтакте
backup